Nichi-Iko Pharmaceutical Co., Ltd.

Text Size

S
M
L

Japanese
English

COMPANYAbout Us

GENERICProduct Information

IRInvestor Relations

CORPORATE SOCIAL RESPONSIBILITYCSR

Nichi-Iko GroupIntegrated Report

INFORMATION

- 09/04/2020
  
  PRESS RELEASE
  
  Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2021(IFRS)
- 08/11/2020
  
  PRESS RELEASE
  
  Year Ending March 31, 2021 Results of 1st Quarter Settlement of Accounts Supplementary Material (Apr.1 to Jun.30 2020)
- 07/30/2020
  
  PRESS RELEASE
  
  Notice on Acquisition of A Company to be Established to Take Over Generic Pharmaceutical Business from Teva Takeda Pharma Ltd.
- 07/30/2020
  
  PRESS RELEASE
  
  Presentation Materials of Acquisition of Generic Pharmaceutical Business from Teva Takeda Pharma Ltd.
- 06/22/2020
  
  PRESS RELEASE
  
  Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 (IFRS)